Who makes First Treatment Period?

First Treatment Period is developed by Beth Israel Deaconess Medical Center.

What development phase is First Treatment Period in?

First Treatment Period is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

First Treatment Period

Beth Israel Deaconess Medical Center · FDA-approved active Small molecule Quality 5/100

At a glance

Generic name	First Treatment Period
Sponsor	Beth Israel Deaconess Medical Center
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Assisted Identification and Navigation of Early Mental Health Symptoms in Children (NA)
Becotatug Vedotin for LA-NPC With a Suboptimal Response to Induction Chemotherapy Combined With Immunotherapy (PHASE2)
Analgesic Efficacy and Safety of Topical VMD-3866 Gel in Management of Pain Induced by Chemotherapy (CIPN) (PHASE2)
Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity (PHASE2)
Hyperpolarized Carbon-13 (13C) Pyruvate Imaging in Patients With Glioblastoma (PHASE1)
Intracalvariosseous Plus Intravenous Antibiotics for Moderate-to-Severe Bacterial Meningitis (NA)
Bevacizumab In Hereditary Hemorrhagic Telangiectasia (PHASE2)
IASTM and Vibration Effects on Pain, Functionality, and Kinesiophobia in Lumbar Disc Herniation (NA)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

First Treatment Period CI brief — competitive landscape report
First Treatment Period updates RSS · CI watch RSS
Beth Israel Deaconess Medical Center portfolio CI